FDA nod to Boehringer Ingelheim's heart disease treatment for dogs 'Vetmedin'
VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs
VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs
Heart failure affects an estimated 64.3 million people worldwide
CIRRUS-HCM, an open-label, multi-part study, evaluates EDG-7500 in patients with obstructive and nonobstructive HCM
The drug is designed to improve functional capacity and reduce symptoms by inhibiting cardiac myosin motor activity
Here's a development that aims to keep your blood pressure in check. Literally!
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
The platform is being introduced to expand access to treatments for people living with chronic conditions
Subscribe To Our Newsletter & Stay Updated